Jardine Matheson's Strategic Priority Execution Remains on Track
Dow Jones
Jul 31
0645 GMT - Jardine Matheson's execution of its strategic priorities outlined during its June investor day remains on track, says DBS Group Research's Elizabelle Pang in a note. The Hong Kong-based conglomerate is likely to continue making further progress on capital recycling in 2H ahead of its I-MED acquisition's expected completion, she says. Jardine's capital recycling and portfolio simplification could be among rerating catalysts for the stock. DBS retains a buy rating and $90.00 target price. The Singapore-listed shares are down 1.0% at $66.91.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.